News

ARV-393 is an investigational orally bioavailable PROteolysis TArgeting Chimera (PROTAC) designed to degrade B-cell lymphoma 6 protein (BCL6), a transcriptional repressor and major driver of B ...
Arvinas is currently progressing multiple investigational drugs through clinical development programs, including vepdegestrant, targeting the estrogen receptor for patients with locally advanced or ...
South Coast Fever ARV defaulters urged to resume treatment Anyone wishing to return to the ARV programme is encouraged to visit their local clinic and speak to a healthcare worker.
The Close the Gap campaign is aimed at urging those defaulting on ARV treatment to return.
ARV-393 shows promising antitumor effects in combination with standard therapies for non-Hodgkin lymphoma, warranting further investigation.
Arvinas, Inc, a clinical-stage biotechnology company working to develop a new class of drugs based on targeted protein degradation, announced that new preclinical combination data for ARV-393 will be ...
Health Cabinet Secretary Deborah Barasa has reaffirmed Kenya's dedication to providing uninterrupted care for individuals living with HIV, despite recent challenges stemming from a freeze in ...
IN a recent statement, the Health and Child Care minister revealed that Zimbabwe has enough antiretroviral (ARV) drugs to last for the next six months.
Zimbabwe's antiretroviral (ARV) medication supplies will be depleted by the end of June if it fails to address a funding gap which has been created by USAID's recent cessation of its aid.
SA self-finances 90% of its ARV programme, receiving only 10% from global sources, Motsoaledi said in a briefing on Pepfar funding.
The National Department of Health must finalise its planning to ensure all eligible individuals in South Africa receive a six-month supply of ARVs, with an implementation plan and timelines to be ...
ARV Studios has opened in the cells area at the former Gilbridge Police Station, a space where prisoners would be held before going to the neighbouring Magistrates Court.